[go: up one dir, main page]

GB9924855D0 - Novel processes - Google Patents

Novel processes

Info

Publication number
GB9924855D0
GB9924855D0 GBGB9924855.1A GB9924855A GB9924855D0 GB 9924855 D0 GB9924855 D0 GB 9924855D0 GB 9924855 A GB9924855 A GB 9924855A GB 9924855 D0 GB9924855 D0 GB 9924855D0
Authority
GB
United Kingdom
Prior art keywords
novel processes
novel
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9924855.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9924855.1A priority Critical patent/GB9924855D0/en
Publication of GB9924855D0 publication Critical patent/GB9924855D0/en
Priority to PCT/GB2000/004060 priority patent/WO2001029031A1/fr
Priority to AU10379/01A priority patent/AU1037901A/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB9924855.1A 1999-10-20 1999-10-20 Novel processes Ceased GB9924855D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9924855.1A GB9924855D0 (en) 1999-10-20 1999-10-20 Novel processes
PCT/GB2000/004060 WO2001029031A1 (fr) 1999-10-20 2000-10-20 Procede de preparation de paroxetine
AU10379/01A AU1037901A (en) 1999-10-20 2000-10-20 Process for the preparation of paroxetine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9924855.1A GB9924855D0 (en) 1999-10-20 1999-10-20 Novel processes

Publications (1)

Publication Number Publication Date
GB9924855D0 true GB9924855D0 (en) 1999-12-22

Family

ID=10863080

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9924855.1A Ceased GB9924855D0 (en) 1999-10-20 1999-10-20 Novel processes

Country Status (3)

Country Link
AU (1) AU1037901A (fr)
GB (1) GB9924855D0 (fr)
WO (1) WO2001029031A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9930577D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Novel process
US7872022B2 (en) 2006-04-03 2011-01-18 Hoffmann-La Roche Inc. Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety
EP2029541B1 (fr) * 2006-04-03 2009-12-30 F. Hoffmann-Roche AG Procede de preparation d'acides beta-arylcarboxyliques ou heteroarylcarboxyliques cycliques enrichis sur le plan enantiomerique
CN101205211B (zh) * 2006-12-19 2011-12-14 北京德众万全药物技术开发有限公司 一种盐酸帕罗西汀重要中间体的制备方法
WO2010069793A1 (fr) 2008-12-16 2010-06-24 F. Hoffmann-La Roche Ag Méthode de préparation d'acides pyrrolidine-3-carboxyliques
CN108486170A (zh) * 2018-03-12 2018-09-04 江苏扬农化工股份有限公司 一种右旋反式二氯菊酸的制备方法
CN108486171A (zh) * 2018-03-12 2018-09-04 江苏扬农化工股份有限公司 一种右旋反式第一菊酸的制备方法
CN115724831A (zh) * 2022-11-18 2023-03-03 上海陶术生物科技有限公司 (3s,4r)-哌啶类化合物的制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process

Also Published As

Publication number Publication date
WO2001029031A1 (fr) 2001-04-26
AU1037901A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
GB9917851D0 (en) Process
GB9922830D0 (en) Processes
GB9914209D0 (en) Process
GB9905512D0 (en) Process
GB9920917D0 (en) Novel process
GB9908814D0 (en) Process
GB9924855D0 (en) Novel processes
GB9924882D0 (en) Novel process
GB9914583D0 (en) Novel process
EP1242378A4 (fr) Nouveaux procedes
GB9926908D0 (en) Novel process
GB9916392D0 (en) Novel process
GB9905418D0 (en) Process
GB9920147D0 (en) Novel process
GB9916187D0 (en) Novel process
GB9903087D0 (en) Process
GB9921243D0 (en) Novel process
GB9915303D0 (en) Novel process
GB9919001D0 (en) Novel process
GB9920146D0 (en) Novel process
GB9923539D0 (en) Novel process
GB9909973D0 (en) Process
GB9911181D0 (en) Process
GB9920937D0 (en) Process
GB9912319D0 (en) Novel compounnds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)